Kezerle Louise, Tsadok Meytal Avgil, Akriv Amichay, Senderey Adi Berliner, Bachrach Asaf, Leventer-Roberts Maya, Haim Moti
Cardiac Electrophysiology and Pacing, Cardiology Department, Soroka Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Clalit Research Institute, Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel.
J Am Coll Cardiol. 2021 Feb 23;77(7):875-884. doi: 10.1016/j.jacc.2020.12.030.
Diabetes mellitus (DM) increases the risk of embolism in nonvalvular atrial fibrillation (NVAF). The association between pre-diabetes and risk of ischemic stroke has not been studied separately in this population.
The purpose of this study was to evaluate whether pre-diabetes is associated with increased risk of stroke and death in patients with NVAF.
We conducted a historical cohort study using the Clalit Health Services electronic medical records. The study population included all members aged ≥25 years, with a first diagnosis of NVAF between January 1, 2010, and December 31, 2016. We compared 3 groups of individuals: those with pre-diabetes, those with diabetes, and normoglycemic patients.
A total of 44,451 cases were identified. The median age was 75 years, and 52.5% were women. During a mean follow-up of 38 months, the incidence rates of stroke (per 100 person-years) were: 1.14 in normoglycemic individuals, 1.40 in those with pre-diabetes, and 2.15 in those with diabetes. In both univariate and multivariate analyses, pre-diabetes was associated with an increased risk of stroke compared with normoglycemic persons (adjusted hazard ratio [adjHR]: 1.19; 95% confidence interval [CI]: 1.01 to 1.4) even after adjustment for CHADS-Vasc risk factors and use of anticoagulants, while diabetes conferred an even higher risk (vs. normoglycemia (adjHR: 1.56; 95% CI: 1.37 to 1.79). The risk for mortality was higher for individuals with diabetes (adjHR: 1.47; 95% CI: 1.41 to 1.54) but not for those with pre-diabetes (adjHR: 0.98; 95% CI: 0.92 to 1.03).
In this cohort of patients with incident NVAF, pre-diabetes was associated with an increased risk of stroke even after accounting for other recognized risk factors.
糖尿病(DM)会增加非瓣膜性心房颤动(NVAF)患者发生栓塞的风险。糖尿病前期与缺血性中风风险之间的关联尚未在该人群中单独研究。
本研究旨在评估糖尿病前期是否与NVAF患者中风和死亡风险增加相关。
我们使用克拉利特医疗服务机构的电子病历进行了一项历史性队列研究。研究人群包括所有年龄≥25岁、在2010年1月1日至2016年12月31日期间首次诊断为NVAF的成员。我们比较了三组个体:糖尿病前期患者、糖尿病患者和血糖正常的患者。
共确定了44451例病例。中位年龄为75岁,52.5%为女性。在平均38个月的随访期间,中风发病率(每100人年)分别为:血糖正常个体为1.14,糖尿病前期个体为1.40,糖尿病个体为2.15。在单变量和多变量分析中,即使在调整了CHADS-Vasc风险因素和抗凝剂使用情况后,糖尿病前期与血糖正常者相比,中风风险仍增加(调整后风险比[adjHR]:1.19;95%置信区间[CI]:1.01至1.4),而糖尿病的风险更高(与血糖正常者相比(adjHR:1.56;95%CI:1.37至1.79)。糖尿病患者的死亡风险更高(adjHR:1.47;95%CI:1.41至1.54),但糖尿病前期患者并非如此(adjHR:0.98;95%CI:0.92至1.03)。
在这一队列新发NVAF患者中,即使考虑了其他公认的风险因素,糖尿病前期仍与中风风险增加相关。